440 results
Innovative approaches to rare PCI complications in NSTEMI
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex PCI scenarios in NSTEMI patients. Participants will learn about rare complications following coronary angioplasty, strategies for identifying the correct culprit lesion, techniques for managing pericardial effusion, and other challenging situations encountered during complex PCI in NSTEMI....
Other coronary interventions: SSO2, angioPy & more
16 May 2024 – From EuroPCR 2024
This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....
Management of PCI complications - Part 1
16 May 2024 – From EuroPCR 2024
This session comprises a series of selected EuroPCR 2024 Clinical Case submissions, focusing on the management of various PCI complications. Participants will explore cases involving coronary physiology challenges, iatrogenic compressive coronary intramural hematoma, misbehaving stents, catheter-induced dissections, and device malfunctions, along with the corresponding bailout techniques...
PCI complications: mistakes in stent placement, stent elongation during implantation & more
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focusing on various PCI complications, including mistakes in stent placement, stent elongation during implantation, and unexpected stent behavior after post-dilatation. The cases are presented with interactive discussions to enhance understanding of these complex scenarios and their management.
Imaging-guided PCI for stent failure - LIVE case
16 May 2024 – From EuroPCR 2024
An 86-year-old male with PAD, a stroke in 2007, and a history of LAD PCI in 2006, presented with unstable angina due to LAD stent restenosis involving D1 and D2, with preserved LV function.
Guided by OCT, the operators performed stenosis preparation using IVL, treated the distal...
Physiology guided post-DCB treatment to safely limit stenting. Validation in complex clinical settings with the optical Optowire III pressure guidewire
16 May 2024 – From EuroPCR 2024
Follow this session to discover how accurate resting index can inform decision-making for DCB in CTO patients and understand the role of physiology in a new PCI workflow for complex MVD. Thus, you will learn about a DCB intention-to-treat strategy guided by post-PCI coronary physiology in...
Mastering the future of PCI with drug-coated balloons
16 May 2024 – From EuroPCR 2024
Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...
Sirolimus-coated balloon: exploring the case- and clinical-based evidences
16 May 2024 – From EuroPCR 2024
Browse this EuroPCR 2024 session to explore the safety and efficacy of sirolimus-coated balloons from pre-clinical data, review MagicTouch data from real-world populations with case-based examples, and learn about the MagicTouch sirolimus-coated balloon clinical programs. Discover insights and takeaways from the significance of the EASTBOURNE subgroups,...
Restoring vessel physiology drives outcomes - The Bioadaptor experience
16 May 2024 – From EuroPCR 2024
Join this session to delve into the unmet needs concerning drug-eluting stents (DES), including poor long-term clinical outcomes, with up to a 50% MACE rate at 10 years, and a non-plateauing 2-3% annual event rate. Explore how DynamX Bioadaptor technology addresses these challenges by maintaining the...
REC-CAGEFREE II, NOTION-2, LANDMARK: Three major late-breaking trials presented at EuroPCR 2024
15 May 2024
The Course Directors have selected 3 major Late Breaking Trials (LBTs) that were presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical practice.
